The diagnostic utility of creatine kinase-MB versus total creatine phosphokinase ratio in patients with non-ST elevation myocardial infarction from unstable angina.

CK-MB CK-MB/CPK ratio Creatine phosphokinase ischemic coronary artery disease rapid diagnosis unstable angina

Journal

SAGE open medicine
ISSN: 2050-3121
Titre abrégé: SAGE Open Med
Pays: England
ID NLM: 101624744

Informations de publication

Date de publication:
2023
Historique:
received: 08 07 2022
accepted: 16 11 2022
entrez: 27 3 2023
pubmed: 28 3 2023
medline: 28 3 2023
Statut: epublish

Résumé

The present study seeks to find a way to quickly and correctly differentiate myocardial infarction from unstable angina by measuring the creatine kinase-MB/creatine phosphokinase ratio and comparing in non-ST elevation myocardial infarction patients with unstable angina at different time intervals, to improve the health quality of patients with coronary artery disease. The present study is a retrospective epidemiological analysis of 260 patients with non-ST elevation myocardial infarction and 260 patients with unstable angina, including age, sex, creatine kinase-MB, and creatine phosphokinase biomarkers at two-time intervals, including referral (4-8 h from the onset of pain) as the first interval, and 8 h after the first sampling was extracted as the second interval. Moreover, the delta of the creatine kinase-MB/creatine phosphokinase ratio during two interval times was measured. In non-ST elevation myocardial infarction patients in the first and second intervals, creatine kinase-MB/creatine phosphokinase ratio was 32.7 and 33.8% higher than the normal laboratory cutoff (positive), respectively, and in the group of unstable angina patients, this index was positive in 31.9 and 30.4% of patients, respectively. There was no significant difference between the mean creatine kinase-MB to creatine phosphokinase index between the patients with non-ST elevation myocardial infarction and unstable angina ( According to our results, creatine kinase-MB/creatine phosphokinase index cannot help differentiate the two groups of non-ST elevation myocardial infarction and unstable angina. However, the findings show that higher levels of creatine kinase-MB enzyme and creatine kinase-MB/creatine phosphokinase delta in the early hours, 4-16 h after the onset of pain in non-ST elevation myocardial infarction patients, can be used to differentiate between non-ST elevation myocardial infarction and unstable angina.

Identifiants

pubmed: 36969724
doi: 10.1177/20503121221148609
pii: 10.1177_20503121221148609
pmc: PMC10034342
doi:

Types de publication

Journal Article

Langues

eng

Pagination

20503121221148609

Informations de copyright

© The Author(s) 2023.

Déclaration de conflit d'intérêts

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Ann Emerg Med. 1992 May;21(5):504-12
pubmed: 1570904
Mayo Clin Proc. 2009 Oct;84(10):917-38
pubmed: 19797781
Crit Rev Anal Chem. 2021 Sep 2;:1-20
pubmed: 34474618
Acad Emerg Med. 1997 Sep;4(9):869-77
pubmed: 9305428
Am J Prev Cardiol. 2021 Mar 27;6:100176
pubmed: 34327499
Arq Bras Cardiol. 2015 Jul;105(1):53-64
pubmed: 25993485
Med Arch. 2017 Oct;71(5):312-315
pubmed: 29284896
Res Cardiovasc Med. 2015 Feb 20;4(1):e25018
pubmed: 25789257
Am J Emerg Med. 2012 Jan;30(1):188-90
pubmed: 21129891
Acad Emerg Med. 1996 Jan;3(1):7-15
pubmed: 8749961
Clin Chem. 2014 Jan;60(1):35-43
pubmed: 24255075
Ann Transl Med. 2016 May;4(10):194
pubmed: 27294090
J Emerg Med. 2003 May;24(4):361-7
pubmed: 12745035
Am Heart J. 2002 Dec;144(6):1012-7
pubmed: 12486425
J Pharm Biomed Anal. 2021 Feb 5;194:113777
pubmed: 33293175
Arch Iran Med. 2019 Apr 01;22(4):204-210
pubmed: 31126179
BMC Emerg Med. 2019 Jul 9;19(1):37
pubmed: 31288735
Circ Res. 2017 Sep 1;121(6):677-694
pubmed: 28860318
J Am Coll Cardiol. 2002 Sep 18;40(6):1044-50
pubmed: 12354426
P R Health Sci J. 2008 Dec;27(4):395-401
pubmed: 19069375
J Thorac Cardiovasc Surg. 2017 Sep;154(3):895-903
pubmed: 28292587
Circulation. 2004 Feb 10;109(5):580-6
pubmed: 14769678
Am J Cardiol. 2000 Dec 15;86(12):1367-71, A5
pubmed: 11113415
Clin Chim Acta. 2016 May 1;456:89-92
pubmed: 26945601
BMC Public Health. 2021 Feb 25;21(1):401
pubmed: 33632204
Vasc Health Risk Manag. 2010 Sep 07;6:691-9
pubmed: 20859540
Vasc Health Risk Manag. 2019 Jan 17;15:1-10
pubmed: 30697054
Sultan Qaboos Univ Med J. 2009 Dec;9(3):231-46
pubmed: 21509305
Eur Heart J. 2000 Sep;21(18):1502-13
pubmed: 10973764
Ann Emerg Med. 2004 Jul;44(1):12-9
pubmed: 15226704

Auteurs

Hassan Motamed (H)

Department of Emergency Medicine, Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Mohammad Mohammadi (M)

Atherosclerosis Research Centre, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Zahra Tayebi (Z)

Department of Emergency Medicine, Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Alireza Rafati Navaei (A)

Department of Emergency Medicine, Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Classifications MeSH